Here are the latest quarterly results of DR. LAL PATHLABS. For more details, see the DR. LAL PATHLABS financial fact sheet and DR. LAL PATHLABS share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-22* |
3
Jun-22* |
3
Sep-22* |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 4,855 | 5,027 | 5,338 | 4,894 | 4,910 | 5,410 | 6,013 | 5,389 | |
Other income | Rs m | 120 | 83 | 87 | 105 | 142 | 144 | 181 | 183 | |
Turnover | Rs m | 4,975 | 5,110 | 5,425 | 4,999 | 5,052 | 5,554 | 6,194 | 5,572 | |
Expenses | Rs m | 3,644 | 3,852 | 3,900 | 3,764 | 3,754 | 3,948 | 4,235 | 3,983 | |
Gross profit | Rs m | 1,211 | 1,175 | 1,438 | 1,130 | 1,156 | 1,462 | 1,778 | 1,406 | |
Depreciation | Rs m | 377 | 359 | 388 | 379 | 376 | 351 | 359 | 360 | |
Interest | Rs m | 119 | 85 | 109 | 91 | 90 | 80 | 78 | 70 | |
Profit before tax | Rs m | 835 | 814 | 1,028 | 765 | 832 | 1,175 | 1,522 | 1,159 | |
Tax | Rs m | 214 | 232 | 304 | 229 | 263 | 339 | 415 | 337 | |
Profit after tax | Rs m | 621 | 582 | 724 | 536 | 569 | 836 | 1,107 | 822 | |
Gross profit margin | % | 24.9 | 23.4 | 26.9 | 23.1 | 23.5 | 27.0 | 29.6 | 26.1 | |
Effective tax rate | % | 25.6 | 28.5 | 29.6 | 29.9 | 31.6 | 28.9 | 27.3 | 29.1 | |
Net profit margin | % | 12.8 | 11.6 | 13.6 | 11.0 | 11.6 | 15.5 | 18.4 | 15.3 | |
Diluted EPS | Rs | 7.4 | 7.0 | 8.7 | 6.4 | 6.8 | 10.0 | 13.3 | 9.8 | |
Diluted EPS (TTM) | Rs | 42.0 | 32.9 | 30.1 | 29.5 | 28.9 | 31.9 | 36.5 | 39.9 | |
Subscriber Feature |
Asian shares rose cautiously on Friday as markets sobered up to the idea that U.S. rate cuts were most likely some time away.